These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 894040)

  • 1. Enhancement of C56-initiated lysis by cell-bound C3 fragments: evidence for a mechanism independent of the prior binding of C56 to C3b.
    Yamamoto KI; Lint TF; Gewurz H
    J Immunol; 1977 Oct; 119(4):1346-50. PubMed ID: 894040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reaction of an activated complex of guinea-pig complement components, C56, with unsensitized erythrocytes and with erythrocytes carrying C3b molecule.
    Tamura N; Baba AS
    Immunology; 1976 Jul; 31(1):151-8. PubMed ID: 1027719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine.
    McLeod B; Baker P; Behrends C; Gewurz H
    Immunology; 1975 Feb; 28(2):379-90. PubMed ID: 47309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C567-initiated cytolysis of lymphoid cells: description of the phenomenon and studies on its control by C567 inhibitors.
    Baker PJ; Lint TF; Mortensen RF; Gewurz H
    J Immunol; 1977 Jan; 118(1):198-202. PubMed ID: 830747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.
    McLeod B; Lint TF; Baker P; Behrends C; Gewurz H
    Immunology; 1975 Apr; 28(4):741-54. PubMed ID: 1171082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF; Behrends CL; Baker PJ; Gewurz H
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of C56-initiated lysis by leucocyte cationic proteins, myelin basic proteins and lysine-rich histones.
    Baker PJ; Lint TF; Siegel J; Kies MW; Gewurz H
    Immunology; 1976 Apr; 30(4):467-73. PubMed ID: 818007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
    Miyama A; Kato T; Minoda I; Ueda T; Kashiba S
    Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
    Kitamura H; Tsuboi M; Nagaki K
    Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.
    Lachmann PJ; Thompson RA
    J Exp Med; 1970 Apr; 131(4):643-57. PubMed ID: 4193935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyanate as an inactivator of complement proteins.
    Schultz DR; Arnold PI
    J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the formation of a unique cellular intermediate (EAC14256) from EAC142 and C56.
    Kitamura H; Tsuboi M
    Int Arch Allergy Appl Immunol; 1988; 85(3):322-8. PubMed ID: 3280504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.
    Baker PJ; Lint TF; McLeod BC; Behrends CL; Gewurz H
    J Immunol; 1975 Feb; 114(2 Pt 1):554-8. PubMed ID: 1168218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the inhibition of C56-initiated lysis (reactive lysis). II. C567-INH--an inhibitor of the C567 trimolecular complex of complement.
    McLeod BC; Baker P; Gewurz H
    Int Arch Allergy Appl Immunol; 1974; 47(4):623-32. PubMed ID: 4415956
    [No Abstract]   [Full Text] [Related]  

  • 19. C3-independent immune haemolysis: haemolysis of EAC14oxy2 cells by C5-C9 without participation of C3.
    Kitamura H; Matsumoto M; Nagaki K
    Immunology; 1984 Nov; 53(3):575-82. PubMed ID: 6237987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.
    McLeod B; Baker P; Gewurz H
    Immunology; 1975 Jan; 28(1):133-49. PubMed ID: 1116868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.